Hartman, Rach E; Rao, P S S; Churchwell, Mariann D; Lewis, Susan J
description
Diabetic Kidney Disease (DKD) involves multifaceted pathophysiology which increases the risk of cardiorenal events and mortality. Conventional therapy is limited to renin-angiotensin aldosterone system inhibition and management of hyperglycemia and hypertension. Recent clinical trials have demonstrated promising nephroprotective effects of antihyperglycemic agents thus modifying guideline treatment recommendations for type 2 diabetic patients with chronic kidney disease.
https://doi.org/10.1080/13543784.2020.1811231
